ClinicalTrials.gov
public full text
Public Domain
A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers
NAC-preHD is a phase II randomized placebo controlled study of oral NAC among premanifest HD gene expansion carriers, with clinical and radiological outcome at three years.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study#863152
- Huntington's Disease Young Adult Study 2.0#1245499
- Preregistration Works: Increased Reporting Quality, Internal Validity, and Protocol Adherence in Animal Studies#16071
- Preregistration Works: Increased Reporting Quality, Internal Validity, and Protocol Adherence in Animal Studies#15937
- Michigan Early Disease Progression Cohort#1371946
Record · ID 1340137
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive